Oscar Health, Inc. (OSCR) - Form 8-K Summary
Business Context and Reporting Period
Oscar Health, Inc., a Delaware corporation, filed this Current Report on Form 8-K on August 6, 2025. The filing announces the Company's financial results for the quarter ended June 30, 2025. The report incorporates a press release (Exhibit 99.1) by reference but explicitly states that the information within Item 2.02 and the exhibit is not deemed "filed" under Section 18 of the Exchange Act.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. Consequently, the following metrics are not available in this text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific details regarding material changes in financial condition or operations compared to the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
This specific 8-K text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information is contained within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q2 2025 revenue, net loss, and adjusted EBITDA figures.
- Verify membership growth and medical loss ratio (MLR) trends in the full press release.
- Check for any updates to full-year 2025 financial guidance provided in the press release.
- Confirm the status of the Company's cash position and liquidity runway as detailed in the full report.